Education
About Us
Working with TipRanks
Follow Us
Peptidream (PPTDF)
:PPTDF
PPTDF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$10.00 - $22.34
Previous CloseN/A
Volume10.00
Average Volume (3M)134.00
Market Cap
$1.32B
Enterprise Value$198.19B
Total Cash (Recent Filing)$33.33B
Total Debt (Recent Filing)$18.98B
Price to Earnings (P/E)15.5
Beta0.68
Next Earnings
Nov 06, 2025EPS Estimate
0.22Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding130,010,400
10 Day Avg. Volume149
30 Day Avg. Volume134
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap149.59
Enterprise Value/Revenue10.38
Enterprise Value/Gross Profit25.71
Enterprise Value/Ebitda-51.76
Forecast
1Y Price Target
$10.16Price Target Upside-7.04% Downside
Rating ConsensusHold
Number of Analyst Covering0
Peptidream News
PPTDF FAQ
What was Peptidream ’s price range in the past 12 months?
Peptidream lowest stock price was $10.00 and its highest was $22.34 in the past 12 months.
What is Peptidream ’s market cap?
Peptidream ’s market cap is $1.32B.
When is Peptidream ’s upcoming earnings report date?
Peptidream ’s upcoming earnings report date is Nov 06, 2025 which is in 66 days.
How were Peptidream ’s earnings last quarter?
Peptidream released its earnings results on Aug 07, 2025. The company reported -$0.057 earnings per share for the quarter, missing the consensus estimate of $0.069 by -$0.127.
Is Peptidream overvalued?
According to Wall Street analysts Peptidream ’s price is currently Overvalued.
Does Peptidream pay dividends?
Peptidream does not currently pay dividends.
What is Peptidream ’s EPS estimate?
Peptidream ’s EPS estimate is 0.22.
How many shares outstanding does Peptidream have?
Peptidream has 130,010,400 shares outstanding.
What happened to Peptidream ’s price movement after its last earnings report?
Peptidream reported an EPS of -$0.057 in its last earnings report, missing expectations of $0.069. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Peptidream ?
Currently, no hedge funds are holding shares in PPTDF
Company Description
Peptidream
PeptiDream Inc., a biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics. The company develops its products based on its Peptide Discovery Platform System, a drug finding platform for the development of peptides. It has a collaborative research and exclusive license agreement with Takeda Pharmaceutical Company Limited to develop peptide drug conjugates for neuromuscular diseases. The company was incorporated in 2006 and is headquartered in Kawasaki, Japan.
PPTDF Company Deck
PPTDF Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a largely positive outlook for the company with strong financial performance and promising pipeline developments, despite some challenges in specific segments and uncertainties in deal closures.View all PPTDF earnings summariesTechnical Analysis
Ownership Overview
―
Insiders
2.64% Mutual Funds
― Other Institutional Investors
93.78% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---